The Percept RC, a rechargeable neurostimulator, is the latest device in the company’s Percept device family, which includes another neurostimulator, technology that receives and records brain signals and directional leads, according to a Jan. 8 Medtronic news release. The system treats patients with movement disorders such as Parkinson’s disease and epilepsy.
Medtronic also recently earned FDA approval for its irregular heartbeat device and put funding into the expansion of its GI Genius module.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
